▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | GreenCity | Italian Channel Awards | Italian Project Awards | ...

BranchLab Launches Privacy-Safe Healthcare Advertising Solution with Seed Funding Round

BranchLab, a data science company developing advanced AI software that enables healthcare brands to reach the right consumers, today announced the closing of a seed funding round led by newark venture...

Business Wire

Amid increased state and industry regulations, BranchLab provides a new solution for healthcare and pharma brands to reach consumers in a privacy-compliant way

NEW YORK: BranchLab, a data science company developing advanced AI software that enables healthcare brands to reach the right consumers, today announced the closing of a seed funding round led by newark venture partners (or nvp). The funding will be used to accelerate product development and market expansion for BranchLab's industry-leading, privacy-safe healthcare advertising solutions for TV. In addition to nvp, Aperiam, venture capital firm, also took part in the seed round, among many other strategic investors.

BranchLab was launched in February of this year and founded by adtech and healthcare advertising veterans Josh Walsh, CEO; Michael Parkes, President and Chief Revenue Officer; and Chris Cagle, Chief Technology Officer. Understanding the implications that cookie and broader ID deprecation and increased privacy regulations like My Health My Data will have on health and pharmaceutical advertising, the founders created an “ID-less” solution for bridging the gap between real world health data and advertising with the aim of increasing TV advertising performance while prioritizing privacy.

“Regulations on personal data and healthcare are moving at the speed of light and we see an incredible opportunity to help healthcare and pharmaceutical brands not only navigate these changes but help future proof their solutions,” said BranchLab CEO, Josh Walsh. “We believe new regulations prohibiting the connection of persistent IDs to consumer health data will become the norm across the industry. This means the existing way audiences are built will need to be replaced and advertisers will need an entirely new privacy-safe and scalable solution to effectively reach their patient audiences and drive outcomes. We believe BranchLab is that solution.”

BranchLab's database, HealthGraph™, aggregates anonymized data from over 300 million US residents and their healthcare journeys, including data on 2.1 million healthcare providers. Built atop a secure cleanroom environment, HealthGraph™ is updated weekly with various healthcare data points, ensuring its comprehensiveness and relevance. Leveraging this unique data asset, BranchLab applies machine learning to create comprehensive audience models from the underlying anonymized data. These models incorporate billions of data points to assign value to media across TV environments enabling targeted advertising, as well as in-flight campaign optimization.

The oversubscribed seed funding round signifies investor confidence in BranchLab's innovative approach to healthcare advertising. The funding will fuel the company's growth and solidify its position as a leader in the privacy-first advertising landscape. Healthcare accounts for one of the largest advertising spends by vertical in the US, which reached $23.5 billion in 2023 and is projected to reach almost $34 billion by 2032 according to the IMARC Group.

"nvp is committed to supporting best-in-class founders working to transform industries and the team and mission of BranchLab epitomizes this spirit. Their groundbreaking approach to prioritizing consumer privacy and increasing advertising performance addresses critical market needs while also paving the way for a more privacy-forward and inclusive advertising ecosystem for pharmaceutical manufacturers,” said Vaughn Crowe, Managing Partner at newark venture partners. “We look forward to working alongside BranchLab as they reinvent healthcare advertising for the 21st century."

"In an era of significant shifts, including the deprecation of third-party cookies, enhanced regulations, and the power of AI, the advertising landscape is transforming. BranchLab is leading this evolution in the healthcare sector with innovative AI solutions and a strong commitment to privacy and safety," said Eric Franchi, General Partner at Aperiam. "We are thrilled to support proven teams like BranchLab's founders as they revolutionize healthcare advertising, helping consumers find the right healthcare solutions while protecting their personal data."

About BranchLab

BranchLab is a data science company developing advanced AI software, enabling healthcare brands to reach the right consumers while setting a new bar for privacy standards. BranchLab operates in the U.S. and is based in New York with offices in Colorado and Pennsylvania. For more information, please visit BranchLab.com.

About newark venture partners (nvp)

nvp backs exceptional founders building the next generation of game-changing enterprise software businesses anywhere in the world. Our tight-knit team of investment professionals are builders at heart, executing with a startup mindset and decades of operational experience to support entrepreneurs on their journey from pilot to scale. For more information visit newark.vc.

About Aperiam

Aperiam is a full-cycle investment and advisory firm founded by pioneers and operators in advertising technology. Established in 2017, Aperiam focuses on three core areas: incubation, investment, and advisory/activation. Committed to building, investing in, and advising companies that define the future of advertising and marketing, Aperiam provides unparalleled access to innovation and insights. For more information, please visit www.aperiam.vc.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

Axyon AI: Italian Artificial Intelligence for Finance applications

Axyon AI offers an AI platform specifically designed for asset management, with several interesting strengths for those approaching machine/deep learning…

Italian Artificial Intelligence tackles medical emergencies at sea

Mermaid-AI is a telehealth platform at sea based on a visor equipped with an AR, medical Artificial Intelligence algorithms, satellite communications…

Gyala: a new "Made in Italy" cybersecurity

With a proven track record in the defence field, Gyala now also brings its cybersecurity technologies to the wider enterprise audience

ITALIAN PROJECT AWARDS 2023: the best IT projects of the year, awarded

Now in its third edition, the initiative is targeted at the ICT professional world and honours projects based on innovative ideas and technologies, realised…

Most read

AHSG Announces Leadership Transition as CEO Mark Smith Joins Board of…

AHSG, a technology-driven, healthcare workforce solutions company, today announced Mark Smith will be stepping down at the end of June as Chief Executive…

Verituity Raises $18.8M to Accelerate its B2B and B2C Verified Payout…

Verituity, a leading provider of intelligent, verified payouts solutions, announced the successful close of an $18.8 million funding round led by Sandbox…

HubStar Launches H2O, a Revolutionary New Approach to Optimizing Occupancy…

HubStar, a leader in dynamic workplace management technology, today announced the launch of H2O, the first ever hybrid occupancy platform designed to…

Capco announces Karl Canty as new US Insurance Partner

Capco, the global technology and management consultancy, has appointed Karl Canty as a new Partner within the company’s US Insurance practice, based in…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!